Latest Postherpetic neuralgia Stories

2011-09-08 10:12:48

(Ivanhoe Newswire) — If you have pain that just won´t go away, don´t give up hope. The mystery may be solved thanks to a recent study. Dr. Andrew Moore and his colleagues at the Oxford Pain Research Unit at Oxford University, have evaluated the effect of commonly used painkillers at expected doses to discover what works and what doesn´t. Acute pain occurs when tissue is damaged by an injury or as a result of surgery. The pain felt after surgery happens because...

2011-09-07 12:15:48

A Cochrane Review of data relating to about 45,000 patients involved in approximately 350 individual studies has provided an evaluation of the effect you can expect to get if you take commonly used painkillers at specific doses. The review also identifies pain killers for which there is only poor or no reliable evidence. This review will help doctors and patients to make evidence informed decisions of which pain killers to use, and is published in the latest edition of The Cochrane Library....

2011-08-12 07:00:00

SAN MATEO, Calif., Aug. 12, 2011 /PRNewswire/ -- NeurogesX, Inc. (NASDAQ: NGSX), a biopharmaceutical company focused on developing and commercializing novel pain management therapies, announced today that Stephen Ghiglieri, Executive Vice President, Chief Operating Officer and Chief Financial Officer, is scheduled to present at the 2011 Wedbush Life Sciences: Management Access Conference to be held August 16-17, 2011, at Le Parker Meridien in New York, NY. Mr. Ghiglieri will also be...

2011-08-09 07:00:00

SAN MATEO, Calif., Aug. 9, 2011 /PRNewswire/ -- Recent Highlights: Completed equity and debt financing totaling $40 million Qutenza® (capsaicin) 8% patch launch in U.S. building momentum in large U.S. institutions; 432 institutions purchased as of 2Q11, up 34% from 1Q11 Sales of Qutenza to end user customers increased 23% over 1Q11 2Q11 revenue totaled $2.5 million including $0.5 million U.S. Qutenza product revenue EU launch by Astellas advancing, with Qutenza...

2011-08-08 15:06:00

SAN MATEO, Calif., Aug. 8, 2011 /PRNewswire/ -- NeurogesX, Inc. (Nasdaq: NGSX), a biopharmaceutical company focused on developing novel pain management therapies, today announced that it has entered into a $20 million loan agreement with Hercules Technology Growth Capital, Inc. (Nasdaq: HTGC). The loan agreement includes both a $5 million accounts receivable line of credit and a $15 million term loan. Proceeds are expected to be used to further support commercialization activities for...

Latest Postherpetic neuralgia Reference Libraries

2011-01-24 12:56:26

Herpes zoster (or zoster), is known as shingles or zona and is a viral disease characterized by painful skin rash with blisters in a limited area on one side of the body. Initial infection causes chickenpox. Once chickenpox is over the virus remains in the body and can cause shingles. It can become latent in the nerve cell bodies and sometimes in the dorsal root, cranial nerve, or autonomic ganglion. Years after initial infection, another breakout can cause a painful rash. The rash usually...

More Articles (1 articles) »
Word of the Day
  • A landsman who is making his first voyage at sea; a novice who enters naval service from rural life.
According to the OED, a grass-comber is also 'a sailor's term for one who has been a farm-labourer.'